A Single-Arm Retrospective Study to Evaluate Safety and Efficacy in Patients with Acute Hepatitis C Virus (HCV) Infection Treated with 8 Weeks of Glecaprevir/Pibrentasvir

19/04/2021
14/03/2024
EU PAS number:
EUPAS39656
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

h20315-protocol-synopsis-nis-version date 24feb2021

English (163.24 KB - PDF) View document
Updated protocol

p20315-protocol-pmos-amendment1_Redacted

First published: 22/02/2024
English (647.96 KB - PDF) View document
Study results
Study results

P20315-pmos-results-rpt_abstract_Redacted

English (243.07 KB - PDF) View document
Study report
Other information